Results of a phase 1/2 trial demonstrated the efficacy of nelfinavir in combination with lenalidomide and dexamethasone for lenalidomide-refractory MM.
A retrospective cohort study identified real-world epidemiology, treatment patterns, and survival outcomes in patients with multiple myeloma in Israel.
A single-center retrospective cohort analysis revealed real-world insights into possible treatments for elderly patients with Hodgkin lymphoma.
Over half of patients with TP53-mutated acute myeloid leukemia who received the combination therapy experienced a response.
A retrospective evaluation of patients with leukemia or lymphoma treated with CAR-T therapy determined their likelihood of experiencing refractory colitis associated with the treatment.
A treatment delay of 6 months was found to result in up to a 67.3% loss in social value for patients receiving chimeric antigen receptor T-cell therapy.
A global task force makes recommendations for safe and appropriate use.
An overview of the findings of an expert panel that examined the unmet clinical needs for patients with Ph-negative MPNs to assess for risks of thrombosis.
Presence of a complex karyotype did not affect progression-free or overall survival.
Results of a subgroup analysis suggest promising clinical activity.
